title: Coronary sinus lead extraction in the era of cardiac resynchronization therapy: single center experience.
abstract: As the number of coronary sinus (CS) lead implantations for cardiac resynchronization therapy increases so will the need for extraction of these leads. The safety of extraction of leads from the branches of the CS has not been reported. We reviewed our database of patients undergoing pacemaker lead extraction from January 2002 through February 2004 at our institution. Of 149 patients referred for lead extraction, 14 (9%) had a biventricular device. The indications for lead extraction were infection, lead malfunction, and exit block. The duration of CS lead implants ranged between 2 and 43 months (mean 17 months). All 14 CS leads were removed successfully using nonsurgical lead extraction techniques. Three leads that were in place the longest (> or =27 months) were removed via the femoral vein approach due to fibrous attachment of the CS lead body to the other pacemaker leads. The leads were structurally intact and without any significant fibrosis of their tips upon visual inspection. There were no major complications of CS laceration, hypotension, pericardial effusion, or excessive blood loss associated with any of the extraction procedures. CS leads were removed safely, successfully and with relative ease based on our experience in this small cohort of patients.
authors.affiliation: Memorial Heart Institute, Long Beach Memorial Medical Center, Long Beach, California 90806, USA.
authors.forename: Babak
authors.initials: B
authors.lastname: Kasravi
authors.forename: Serge
authors.initials: S
authors.lastname: Tobias
authors.forename: Mary J
authors.initials: MJ
authors.lastname: Barnes
authors.forename: John C
authors.initials: JC
authors.lastname: Messenger
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D003331:Coronary Vessels; D020878:Device Removal / Q000379:methods; D004554:Electric Countershock; D004868:Equipment Failure; D006801:Humans; D008875:Middle Aged; D010138:Pacemaker, Artificial / Q000009:adverse effects; D016459:Prosthesis-Related Infections / Q000628:therapy